|
1
|
Meltzer PS and Helman LJ: New horizons in
the treatment of osteosarcoma. N Engl J Med. 385:2066–2076. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dixon SJ, Lemberg KM, Lamprecht MR, Skouta
R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS,
et al: Ferroptosis: An iron-dependent form of nonapoptotic cell
death. Cell. 149:1060–1072. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jiang X, Stockwell BR and Conrad M:
Ferroptosis: Mechanisms, biology and role in disease. Nat Rev Mol
Cell Biol. 22:266–282. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen X, Kang R, Kroemer G and Tang D:
Broadening horizons: The role of ferroptosis in cancer. Nat Rev
Clin Oncol. 18:280–296. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liang WC, Ren JL, Wong CW, Chan SO, Waye
MMY, Fu WM and Zhang JF: LncRNA-NEF antagonized epithelial to
mesenchymal transition and cancer metastasis via cis-regulating
FOXA2 and inactivating Wnt/β-catenin signaling. Oncogene.
37:1445–1456. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang Y, Zeng X, Wang N, Zhao W, Zhang X,
Teng S, Zhang Y and Lu Z: Long noncoding RNA DANCR, working as a
competitive endogenous RNA, promotes ROCK1-mediated proliferation
and metastasis via decoying of miR-335-5p and miR-1972 in
osteosarcoma. Mol Cancer. 17:892018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bhan A, Soleimani M and Mandal SS: Long
noncoding RNA and cancer: A new paradigm. Cancer Res. 77:3965–3981.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Han Y, Gao X, Wu N, Jin Y, Zhou H, Wang W,
Liu H, Chu Y, Cao J, Jiang M, et al: Long noncoding RNA LINC00239
inhibits ferroptosis in colorectal cancer by binding to Keap1 to
stabilize Nrf2. Cell Death Dis. 13:7422022. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lin Z, Song J, Gao Y, Huang S, Dou R,
Zhong P, Huang G, Han L, Zheng J, Zhang X, et al: Hypoxia-induced
HIF-1α/lncRNA-PMAN inhibits ferroptosis by promoting the
cytoplasmic translocation of ELAVL1 in peritoneal dissemination
from gastric cancer. Redox Biol. 52:1023122022. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li L, Zhang Y, Gao Y, Hu Y, Wang R, Wang
S, Li Y, He Y and Yuan C: LncSNHG14 promotes nutlin3a resistance by
inhibiting ferroptosis via the miR-206/SLC7A11 axis in osteosarcoma
cells. Cancer Gene Ther. 30:704–715. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu K, Ni JD, Li WZ, Pan BQ, Yang YT, Xia
Q and Huang J: The Sp1/FOXC1/HOTTIP/LATS2/YAP/β-catenin cascade
promotes malignant and metastatic progression of osteosarcoma. Mol
Oncol. 14:2678–2695. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li Z, Zhao L and Wang Q: Overexpression of
long non-coding RNA HOTTIP increases chemoresistance of
osteosarcoma cell by activating the Wnt/β-catenin pathway. Am J
Transl Res. 8:2385–2393. 2016.PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shi CJ, Lv MY, Deng LQ, Zeng WQ, Fu WM and
Zhang JF: Linc-ROR drive adriamycin resistance by targeting
AP-2α/Wnt/β-catenin axis in hepatocellular carcinoma. Cell Biol
Toxicol. 39:1735–1752. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shao J, Shi CJ, Li Y, Zhang FW, Pan FF, Fu
WM and Zhang JF: LincROR mediates the suppressive effects of
curcumin on hepatocellular carcinoma through inactivating
Wnt/β-catenin signaling. Front Pharmacol. 11:8472020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Draghici S, Khatri P, Tarca AL, Amin K,
Done A, Voichita C, Georgescu C and Romero R: A systems biology
approach for pathway level analysis. Genome Res. 17:1537–1545.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chang X, Ma Z, Zhu G, Lu Y and Yang J: New
perspective into mesenchymal stem cells: Molecular mechanisms
regulating osteosarcoma. J Bone Oncol. 29:1003722021. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu J, Song X, Kuang F, Zhang Q, Xie Y,
Kang R, Kroemer G and Tang D: NUPR1 is a critical repressor of
ferroptosis. Nat Commun. 12:6472021. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang Y, Yan D, Liu JB, Tang DL and Chen X:
Protein modification and degradation in ferroptosis. Redox Biol.
75:1032592024. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Weitz SH, Gong M, Barr I, Weiss S and Guo
F: Processing of microRNA primary transcripts requires heme in
mammalian cells. Proc Natl Acad Sci USA. 111:1861–1866. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Partin AC, Ngo TD, Herrell E, Jeong BC,
Hon G and Nam Y: Heme enables proper positioning of Drosha and
DGCR8 on primary microRNAs. Nat Commun. 8:17372017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hattinger CM, Patrizio MP, Fantoni L,
Casotti C, Riganti C and Serra M: Drug resistance in osteosarcoma:
Emerging biomarkers, therapeutic targets and treatment strategies.
Cancers (Basel). 13:28782021. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lei T, Qian H, Lei P and Hu Y:
Ferroptosis-related gene signature associates with immunity and
predicts prognosis accurately in patients with osteosarcoma. Cancer
Sci. 112:4785–4798. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang X, Xia G, Xiao S, Wu S, Zhang L,
Huang J, Zhang W and Cao X: A ferroptosis-related gene signature
associated with immune landscape and therapeutic response in
osteosarcoma. Front Oncol. 12:10249152022. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen X, Li J, Kang R, Klionsky DJ and Tang
D: Ferroptosis: Machinery and regulation. Autophagy. 17:2054–2081.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yao XY, Liu JF, Luo Y, Xu XZ and Bu J:
LncRNA HOTTIP facilitates cell proliferation, invasion, and
migration in osteosarcoma by interaction with PTBP1 to promote
KHSRP level. Cell Cycle. 20:283–297. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liao B, Chen R, Lin F, Mai A, Chen J, Li
H, Xu Z and Dong S: Long noncoding RNA HOTTIP promotes endothelial
cell proliferation and migration via activation of the
Wnt/β-catenin pathway. J Cell Biochem. 119:2797–2805. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tang Y and Ji F: lncRNA HOTTIP facilitates
osteosarcoma cell migration, invasion and epithelial-mesenchymal
transition by forming a positive feedback loop with c-Myc. Oncol
Lett. 18:1649–1656. 2019.PubMed/NCBI
|
|
29
|
Herman AB, Tsitsipatis D and Gorospe M:
Integrated lncRNA function upon genomic and epigenomic regulation.
Mol Cell. 82:2252–2266. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bridges MC, Daulagala AC and Kourtidis A:
LNCcation: lncRNA localization and function. J Cell Biol.
220:e2020090452021. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu R, Li Z, Song E, Hu P, Yang Q, Hu Y,
Liu H and Jin A: LncRNA HOTTIP enhances human osteogenic BMSCs
differentiation via interaction with WDR5 and activation of
Wnt/β-catenin signalling pathway. Biochem Biophys Res Commun.
524:1037–1043. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Luo H, Zhu G, Eshelman MA, Fung TK, Lai Q,
Wang F, Zeisig BB, Lesperance J, Ma X, Chen S, et al:
HOTTIP-dependent R-loop formation regulates CTCF boundary activity
and TAD integrity in leukemia. Mol Cell. 82:833–851.e11. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu X, Chen D, Chen H, Wang W, Liu Y, Wang
Y, Duan C, Ning Z, Guo X, Otkur W, et al: YB1 regulates
miR-205/200b-ZEB1 axis by inhibiting microRNA maturation in
hepatocellular carcinoma. Cancer Commun (Lond). 41:576–595. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li Y, Xing Y, Wang X, Hu B, Zhao X, Zhang
H, Han F, Geng N, Wang F, Li Y, et al: PAK5 promotes RNA helicase
DDX5 sumoylation and miRNA-10b processing in a kinase-dependent
manner in breast cancer. Cell Rep. 37:1101272021. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hu S, Chang J, Ruan H, Zhi W, Wang X, Zhao
F, Ma X, Sun X, Liang Q, Xu H, et al: Cantharidin inhibits
osteosarcoma proliferation and metastasis by directly targeting
miR-214-3p/DKK3 axis to inactivate β-catenin nuclear translocation
and LEF1 translation. Int J Biol Sci. 17:2504–2522. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gao K, Yin J and Dong J: Deregulated WWOX
is involved in a negative feedback loop with microRNA-214-3p in
osteosarcoma. Int J Mol Med. 38:1850–1856. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Cai H, Miao M and Wang Z: miR-214-3p
promotes the proliferation, migration and invasion of osteosarcoma
cells by targeting CADM1. Oncol Lett. 16:2620–2628. 2018.PubMed/NCBI
|
|
38
|
Zhao X, Wang Q, Lin F, Wang X, Wang Y,
Wang J and Wang C: RNA sequencing of osteosarcoma gene expression
profile revealed that miR-214-3p facilitates osteosarcoma cell
proliferation via Targeting ubiquinol-cytochrome c reductase core
protein 1 (UQCRC1). Med Sci Monit. 25:4982–4991. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yao X, Wu L, Gu Z and Li J: LINC01535
promotes the development of osteosarcoma through modulating
miR-214-3p/KCNC4 axis. Cancer Manag Res. 12:5575–5585. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Cheng G, Xu D, Chu K, Cao Z, Sun X and
Yang Y: The effects of MiR-214-3p and Irisin/FNDC5 on the
biological behavior of osteosarcoma cells. Cancer Biother
Radiopharm. 35:92–100. 2020.PubMed/NCBI
|
|
41
|
Zhou J, Xiao C, Zheng S, Wang Q, Zhu H,
Zhang Y and Wang R: MicroRNA-214-3p aggravates ferroptosis by
targeting GPX4 in cisplatin-induced acute kidney injury. Cell
Stress Chaperones. 27:325–336. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Liu F, Jiang LJ, Zhang YX, Xu ST, Liu SL,
Ye JT and Liu PQ: Inhibition of miR-214-3p attenuates ferroptosis
in myocardial infarction via regulating ME2. Biochem Biophys Res
Commun. 661:64–74. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Hashimoto K, Nishimura S, Ito T, Oka N,
Kakinoki R and Akagi M: Clinicopathological assessment of
cancer/testis antigens NY-ESO-1 and MAGE-A4 in osteosarcoma. Eur J
Histochem. 66:33772022. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Chen A, Qiu Y, Yen YT, Wang C, Wang X, Li
C, Wei Z, Li L, Yu L, Liu F and Li R: Expression of cancer-testis
antigens MAGE-A1, MAGE-A4, NY-ESO-1 and PRAME in bone and soft
tissue sarcomas: The experience from a single center in China.
Cancer Med. 14:e707502025. View Article : Google Scholar : PubMed/NCBI
|
